AAAAAA
Results: 26-50/78
Authors:
Belgore, FM
Blann, AD
Li-Saw-Hee, FL
Beevers, DG
Lip, GYH
Citation: Fm. Belgore et al., Plasma levels of vascular endothelial growth factor and its soluble receptor (sFlt-1) in essential hypertension, AM J CARD, 87(6), 2001, pp. 805
Authors:
Blann, AD
Belgore, FM
Constans, J
Conri, C
Lip, GYP
Citation: Ad. Blann et al., Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of Fluvastatin or Fenofibrate, AM J CARD, 87(10), 2001, pp. 1160-1163
Authors:
Goldsmith, IRA
Blann, AD
Patel, RL
Lip, GYH
Citation: Ira. Goldsmith et al., Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen, AM J CARD, 87(1), 2001, pp. 107
Authors:
Byrne, GJ
Ghellal, A
Iddon, J
Blann, AD
Venizelos, V
Kumar, S
Howell, A
Bundred, NJ
Citation: Gj. Byrne et al., Serum soluble vascular cell adhesion molecule-1: Role as a surrogate marker of angiogenesis, J NAT CANC, 92(16), 2000, pp. 1329-1336
Authors:
Goldsmith, IRA
Blann, AD
Patel, RL
Lip, GYH
Citation: Ira. Goldsmith et al., Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aorticvalve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction, HEART, 83(5), 2000, pp. 577-578
Authors:
Belgore, FM
Lip, GYH
Blann, AD
Citation: Fm. Belgore et al., Vascular endothelial growth factor and its receptor, Flt-1, in smokers andnon-smokers, BR J BIOMED, 57(3), 2000, pp. 207-213
Authors:
Blann, AD
Citation: Ad. Blann, Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?, BL COAG FIB, 11(7), 2000, pp. 623-630
Authors:
Lip, GYH
Lydakis, C
Nuttall, SL
Landray, MJ
Watson, RDS
Blann, AD
Citation: Gyh. Lip et al., A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction, J INTERN M, 248(4), 2000, pp. 316-318
Authors:
Lip, GYH
Blann, AD
Beevers, DG
Citation: Gyh. Lip et al., Helicobacter pylori seropositivity, lipid concentrations and haemostatic factors, J INTERN M, 248(4), 2000, pp. 354-355
Authors:
Lip, GYH
Blann, AD
Citation: Gyh. Lip et Ad. Blann, Thrombogenesis and fibrinolysis in acute coronary syndromes - Important facets of a prothrombotic or hypercoagulable state?, J AM COL C, 36(7), 2000, pp. 2044-2046
Authors:
Li-Saw-Hee, FL
Blann, AD
Lip, GYH
Citation: Fl. Li-saw-hee et al., A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation, J AM COL C, 35(7), 2000, pp. 1926-1931
Authors:
Blann, AD
Citation: Ad. Blann, Influence of fluvastatin on levels of von Willebrand factor in cardiac transplant recipients, THROMB HAEM, 84(3), 2000, pp. 514-514
Authors:
Li-Saw-Hee, FL
Edmunds, E
Blann, AD
Beevers, DG
Lip, GYH
Citation: Fl. Li-saw-hee et al., Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levelsin essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy, INT J CARD, 75(1), 2000, pp. 43-47
Authors:
Lip, GYH
Kamath, S
Blann, AD
Citation: Gyh. Lip et al., Haematocrit and plasma viscosity in atrial fibrillation, INT J CARD, 74(1), 2000, pp. 85-86
Authors:
Goldsmith, IRA
Li-Saw-Hee, FL
Blann, AD
Lip, GYH
Citation: Ira. Goldsmith et al., Increased platelet activation and endothelial dysfunction in patients withatrial fibrillation immediately following percutaneous balloon mitral valvuloplasty, CLIN CARD, 23(8), 2000, pp. 587-590
Authors:
Lip, PL
Belgore, F
Blann, AD
Hope-Ross, MW
Gibson, JM
Lip, GYH
Citation: Pl. Lip et al., Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: Relationship to endothelial dysfunction and laser treatment, INV OPHTH V, 41(8), 2000, pp. 2115-2119
Authors:
Blann, AD
Lip, GYH
Citation: Ad. Blann et Gyh. Lip, Left atrial thrombin generation and prothrombin fragment 1+2, CLIN SCI, 99(5), 2000, pp. 411-412
Authors:
Constans, J
Blann, AD
Renard, M
Guerin, V
Conri, C
Citation: J. Constans et al., Soluble thrombomodulin in hypercholesterolaemic patients, LANCET, 355(9198), 2000, pp. 145-145
Authors:
Constans, J
Seigneur, M
Blann, AD
Lestage, B
Resplandy, F
Renard, M
Chaudet, B
Amiral, J
Guerin, V
Boisseau, MR
Conri, C
Citation: J. Constans et al., Endothelial function, platelet activation and coagulation in lower limb occlusive arterial disease during treadmill exercise: Correlations with transcutaneous oxygen pressure, THROMB RES, 99(6), 2000, pp. 557-561
Authors:
Blann, AD
Farrell, A
Picton, A
McCollum, CN
Citation: Ad. Blann et al., Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease, THROMB RES, 97(4), 2000, pp. 209-216
Authors:
Li-Saw-Hee, FL
Blann, AD
Lip, GYH
Citation: Fl. Li-saw-hee et al., Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation, STROKE, 31(4), 2000, pp. 828-833
Authors:
Jilma, B
Blann, AD
Stohlawetz, P
Eichler, HG
Kautzky-Willer, A
Wagner, OF
Citation: B. Jilma et al., Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men, J LA CL MED, 135(3), 2000, pp. 270-274
Authors:
Blann, AD
Lip, GYH
Citation: Ad. Blann et Gyh. Lip, Editorial: Cell adhesion molecules in cardiovascular disease and its risk factors - What can soluble levels tell us?, J CLIN END, 85(5), 2000, pp. 1745-1747
Authors:
Blann, AD
Amiral, J
McCollum, CN
Lip, GYH
Citation: Ad. Blann et al., Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls, ATHEROSCLER, 152(1), 2000, pp. 29-34
Authors:
Belgore, FM
Lip, GYH
Blann, AD
Citation: Fm. Belgore et al., Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia, ATHEROSCLER, 151(2), 2000, pp. 599-599